Evaluating the appropriateness of chemotherapy in a low‐resource cancer centre in sub‐Saharan Africa

To evaluate the appropriateness of chemotherapy use at the Oncology Department of the Bugando Medical Centre of Mwanza, Tanzania.

[1]  Deogratias Katabalo,et al.  Impact of Pharmacist Participation on Chemotherapy Administration Outcomes in a Low-Resource Setting , 2018 .

[2]  L. Quiñones,et al.  State of Art of Cancer Pharmacogenomics in Latin American Populations , 2017, International journal of molecular sciences.

[3]  O. Nanni,et al.  Setting up a community-based cervical screening service in a low-income country: a pilot study from north-western Tanzania , 2017, International Journal of Public Health.

[4]  D. Amadori,et al.  The surgical pathology laboratory in Mwanza, Tanzania: a survey on the reproducibility of diagnoses after the first years of autonomous activity , 2017, Infectious Agents and Cancer.

[5]  P. Ang,et al.  Pharmacogenetics of ABCB5, ABCC5 and RLIP76 and doxorubicin pharmacokinetics in Asian breast cancer patients , 2016, The Pharmacogenomics Journal.

[6]  D. Amadori,et al.  The Mwanza Cancer Project. , 2016, The Lancet. Oncology.

[7]  J. Maurice.  Mounting cancer burden tests Africa's health resources , 2015, The Lancet.

[8]  O. Nanni,et al.  Differences in biological features of breast cancer between Caucasian (Italian) and African (Tanzanian) populations , 2014, Breast Cancer Research and Treatment.

[9]  E. Audureau,et al.  Improving access to care in low and middle-income countries: institutional factors related to enrollment and patient outcome in a cancer drug access program , 2013, BMC Health Services Research.

[10]  O. Olopade,et al.  Treatment of cancer in sub-Saharan Africa. , 2013, The Lancet. Oncology.

[11]  Jeffrey D Sachs,et al.  Expansion of cancer care and control in countries of low and middle income: a call to action , 2010, The Lancet.

[12]  A. Khrunin,et al.  Genetic polymorphisms and the efficacy and toxicity of cisplatin-based chemotherapy in ovarian cancer patients , 2010, The Pharmacogenomics Journal.

[13]  Lara Stein,et al.  Part I: Cancer in Indigenous Africans--burden, distribution, and trends. , 2008, The Lancet. Oncology.

[14]  P. Ndom.  Challenges of anticancer chemotherapy in Africa. , 2008, The Canadian journal of urology.

[15]  I. Magrath.  Chemotherapy in developing countries--is less better? , 2003, European journal of cancer.

[16]  The Lancet Oncology.  Cancer control in Africa: infrastructure, not philanthropy. , 2017, The Lancet. Oncology.